Current NDC auxiliary source row compounder:1349

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 71300-6631
Product Ndc: 71300-6631
Product Ndc Digits: 713006631
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Dexamethasone sodium phosphate
Proprietary Name Suffix: [empty]
Nonproprietary Name: Dexamethasone sodium phosphate
Dosage Form Name: SOLUTION
Route Name: TOPICAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Nubratori Inc.
Establishment Name: Nubratori Inc.
Establishment Fei: [empty]
Substance Name: DEXAMETHASONE SODIUM PHOSPHATE
Active Ingredients Info: 4 mg/1 mL
History Active Ingredients Raw: DEXAMETHASONE SODIUM PHOSPHATE
History Active Ingredients Info Raw: 4 mg/1 mL
History Dosage Raw: SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 71300-6631-1
Package Ndc: 71300-6631-1
Package Ndc Digits: 7130066311
Package Ndc11: 71300663101
Package Description: 1 BOTTLE in 1 BOX (71300-6631-1) > 5 mL in 1 BOTTLE
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:1349
Source Row Number: 1349
Source Row Hash: 85b14e5a660c8df4a173cebc5ca4ef1653b43acc279ebe5ce413fb7cd7c1abf2
Import Run Id: 20261021T042902Z
Loaded At: 2026-10-21 04:33:26

Exact raw FDA source fields#

{
    "ROUTENAME": "TOPICAL",
    "PRODUCTNDC": "71300-6631",
    "DEASCHEDULE": "",
    "LABELERNAME": "Nubratori Inc.",
    "SUBSTANCENAME": "DEXAMETHASONE SODIUM PHOSPHATE",
    "DOSAGEFORMNAME": "SOLUTION",
    "NDCPACKAGECODE": "71300-6631-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Dexamethasone sodium phosphate",
    "REPORTINGPERIOD": "2025-1",
    "NONPROPRIETARYNAME": "Dexamethasone sodium phosphate",
    "PACKAGEDESCRIPTION": "1 BOTTLE in 1 BOX (71300-6631-1)  > 5 mL in 1 BOTTLE",
    "ACTIVEINGREDIENTSINFO": "4 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:1349
Source Row Number: 1349
Status Scope: package
Lookup Ndc: 71300-6631-1
Lookup Ndc Digits: 7130066311
Product Ndc: 71300-6631
Product Ndc Digits: 713006631
Package Ndc: 71300-6631-1
Package Ndc Digits: 7130066311
Package Ndc11: 71300663101
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 85b14e5a660c8df4a173cebc5ca4ef1653b43acc279ebe5ce413fb7cd7c1abf2
Import Run Id: 20261021T042902Z
Loaded At: 2026-10-21 04:33:26